1. Advances in evidence-based antenatal care David Ellwood Professor of Obstetrics & Gynaecology Primary Care Network, UQCCR, 28th August 2013

2. Numbers of births Primary Care Network, UQCCR, 28th August 2013

3. Maternal age in 2010  Median age of all mothers was 30 yrs  3.9% of mothers were <20  23.0% of mothers were over 35  4.1% were over 40  Significant increase in the proportion of mothers >35 over last 20 years Primary Care Network, UQCCR, 28th August 2013

4. Changes in first-time mothers Primary Care Network, UQCCR, 28th August 2013

5. ‘The most significant reproductive threat of modern times has to be the overweight & obesity epidemic’

6. Overweight & obesity  Major risk factor which impacts on all types of adverse outcome in pregnancy & birth  No national data previously reported  Only 5 jurisdictions were able to provide data on BMI at booking for the 2010 collection »49.9% had a booking BMI of >25 »22.4% were >30 (obese) »Approximately 4% have BMI >40 (ACT data) »3 per 1000 have BMI >50 (AMOSS) Primary Care Network, UQCCR, 28th August 2013

7. Smoking in pregnancy  Data quality is variable but has been improving over time  All states & territories submitted data in 2010  Overall rate was 13.5% (cf. 16.2% in 2007) »Rates vary from 11.2% (NSW & ACT) to 25.5% (TAS) »36.7% of teenage mothers admitted smoking in pregnancy (cf. 39% in 2007) Primary Care Network, UQCCR, 28th August 2013

8. Key points about ANC  Antenatal care is an intervention that is used for over 300,000 women each year in Australia  There are a number of important elements »screening for maternal and fetal health »education and access to information »emotional and psychological support  Antenatal care is delivered in many different settings and by as variety of health care professionals  It is expensive, and until recently, there were no national guidelines which are evidence-based Primary Care Network, UQCCR, 28th August 2013

9. Cost estimates for ANC?  300,000 women per year in Australia  10 visits each ($50-70 each)  Antenatal investigations ($200-300)  Ultrasounds x 2 ($140-500)  These estimates vary from $250M to 450M per annum across Australia Primary Care Network, UQCCR, 28th August 2013

10. Evidence-based Antenatal Care Clinical Practice Guidelines Antenatal care – module 1 Published in 2012 (Co-Chairs: Professors Caroline Homer & Jeremy Oats) Primary Care Network, UQCCR, 28th August 2013

11. Grades of Evidence Grade A: Body of evidence can be trusted to guide practice Grade B: Body of evidence can be trusted to guide practice in most situations Grade C: Body of evidence provides some support for recommendations but care should be taken in its application Grade D: Body of evidence is weak and recommendation must be applied with caution CBR: Recommendation formulated in the absence of quality evidence PP: Area is beyond the scope of the systematic literature review and advice was developed by the EAC and/or the Working Group for Aboriginal and Torres Strait Islander Women’s Antenatal Care Primary Care Network, UQCCR, 28th August 2013

12. Evidence-based antenatal investigations  First trimester (Maternal Health Screening) »Ultrasound (8 to 14 weeks) for those who are uncertain of their conception date (B) »Asymptomatic bacteruria testing early in pregnancy (A) »Vitamin D screening to those with risk factors (CBR) »Give information about testing for chromosome abnormalities Primary Care Network, UQCCR, 28th August 2013

13. Antenatal Investigations (2)  Recommended infection screens  HIV testing at first antenatal visit (B)  Hepatitis B testing (A)  Hepatitis C only for those with identifiable risk factors (C)  Syphilis testing at first antenatal visit (B)  Rubella immunity (B)  Chlamydia for women under 25 (C) Primary Care Network, UQCCR, 28th August 2013

14. Nutritional supplements in pregnancy  Folic Acid (500 micrograms per day) from 12 weeks before until 12 weeks after conception (A)  No benefit in taking Vitamins A, C or E supplements and may cause harm (B)  Iodine supplementation (150 micrograms per day) for all pregnant women (CBR)  No routine iron supplementation (B) Primary Care Network, UQCCR, 28th August 2013

15. Two recent and controversial aspects  Screening and/or testing for chromosomal abnormalities  Screening for gestational diabetes (Both of these are significantly age-related….) Primary Care Network, UQCCR, 28th August 2013

16. Screening for Chromosomal Abnormalities  Combined 1st trimester screening (nuchal translucency & PAPP-A/HCG) has been a successful program for 10-15 years  It is safe, effective, and acceptable to most women  Advantages »relatively inexpensive ($100-150) »high detection rate (93 to 95%)  Disadvantages »high screen positive rate (5%) »diagnostic test is invasive »hard to understand (adjusted risk) Primary Care Network, UQCCR, 28th August 2013

17. Non-invasive fetal testing  Fetal DNA from the maternal circulation can now be used to diagnose fetal aneuploidy (although current approach is to confirm with CVS or amniocentesis)  Detection rates for T21, T18 and 13, and sex chromosome aneuploidy are > 99%  But is this an improvement on the current approach?  How should it be judged? »effectiveness »cost »acceptability Primary Care Network, UQCCR, 28th August 2013

18. Options for screening/diagnosis of T21 1.Continue with current approach of NT/SS followed by CVS or amniocentesis 2.NT/SS followed by NIFT for those who are screen positive 3.NT/SS for low risk women and NIFT for high risk (a) > 35 years (23%) (b) > 40 years (4%) 4.NIFT for all women who want it (and can afford to pay for it…) Primary Care Network, UQCCR, 28th August 2013

19. Cost comparisons for different DS approaches Primary Care Network, UQCCR, 28th August 2013 Model 1Model 2Model 3.AModel 3.BModel 4 No. of DS detected in 100,000 women (220) 205203214 218 Procedure-related losses34227333 Low Cost Total cost ($)13,780,25014,121,48626,822,32116,174,48270,144,326 Cost per person ($)139141268162701 Cost per DS detected ($)67,22169,564125,33875,582321,763 High Cost Total cost ($)48,250,00047,439,20067,291,10051,795,030136,461,100 Cost per person ($)4824786735181,364 Cost per DS detected ($)235,826235,537314,458242,033625,968

20. Which way to choose?  Using NIPT alone will maximise the diagnoses of DS, reduce the overall procedure-related loss rate, but is extremely expensive  Using NIPT as a ‘second screen’ reduces the numbers of CVS/amniocenteses performed (and therefore the procedure – related losses) but does add time to the process  The most cost-effective approach is using NIPT only for those who are very high risk and are likely to need invasive testing regardless of the screening result  If NIPT could be accepted as the diagnostic test as well this would eliminate the need for CVS or amniocentesis  If the cost of NIPT reduced to about $150 per patient it would be cost-comparable, with the highest detection rate and virtually no procedure-related losses Primary Care Network, UQCCR, 28th August 2013

21. Screening for Gestational Diabetes  Current approach is 50g glucose load for all women, with 75g GTT for screen +ve women (>7.8mmol/L)  Recent recommendations from ADIPS are; »75g GTT for all & early testing (as soon as possible after conception) for high risk women »No need for 3 day CH 2 0 dietary loading »Change criteria for diagnosis of GDM;  Fasting BSL reduced to 5.0mmo;/L  Add a 1 hour criterion (>10.0mmol/L)  Increase the 2 hour cut-off to 8.5mmol/L Primary Care Network, UQCCR, 28th August 2013

22. Problems with these changes  This will lead to an increase in the number of cases of GDM diagnosed, and therefore increased numbers who need to be managed by a multi-disciplinary team  Compliance is a problem with the current approach so it is likely that this will reduce further  Unknown fetal effects of treating more women with insulin from earlier in pregnancy  There has been no rigorous cost-benefit analysis to support this change Primary Care Network, UQCCR, 28th August 2013

23. CONCLUSIONS  Antenatal care now has a rigorous, evidence-based guideline  Unfortunately, much of the evidence for some of the recommendations is quite poor  Antenatal care is very expensive, and it is important that cost-benefit analyses are done to inform best practice Primary Care Network, UQCCR, 28th August 2013